Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUISSE MPC2: Autologous Muscle Precursor Cells for Stress Urinary Incontinence
NCT05534269Phase 2Completed
- Sponsor
- University of Zurich
- Start
- Oct 2022
- Primary completion
- Jul 2025
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous muscle precursor cells in stress urinary incontinence (SUI), sponsored by University of Zurich. Started Oct 2022; status: completed.
02
Drugs
autologous muscle precursor cells
03
Conditions
stress urinary incontinence (SUI)
Beyond the preview
Go deeper on NCT05534269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05534269.